What You Should Know:
– Mentaily, a company developing AI-powered tools for mental health assessment, triage, and the diagnosis of mental disorders secures $3M seed funding round led by a US-based family office and Israeli family offices, with significant participation from impact funds The Rashi Foundation and Sheatufim, alongside prominent digital health angel investors.
– Founded in 2024, Mentaily is focused on addressing complex mental health needs, particularly those emerging in times of crisis and trauma. The company’s flagship AI-powered product, LIV, is designed to simulate clinical psychiatric intake sessions, aiding in the diagnosis of psychological distress and mental illness with high accuracy.
Addressing a Growing Global Mental Health Crisis
The new funding arrives at a critical time, with mental health conditions on the rise globally while access to adequate support remains limited. In the United States alone, an estimated one in five individuals is affected by mental health issues, and over 120 million Americans reside in areas with insufficient mental health services. This stark reality underscores the urgent need for innovative technologies like Mentaily’s LIV to augment existing mental health interventions and broaden access to care.
Introducing LIV: AI-Powered Psychiatric Intake and Triage
Mentaily’s LIV platform utilizes AI to conduct multilingual, natural-language conversations with individuals through voice or text, optionally featuring an AI avatar. This creates a personalized and scalable approach to mental health triage and assessment. The technology was developed through a collaborative effort involving the ARC (Accelerate, Redesign, Collaborate) Innovation Center and the Drora and Pinchas Zakai Department of Psychiatry at Israel’s renowned Sheba Medical Center, along with global technology leaders Microsoft and KPMG.
LIV simulates detailed clinical psychiatric intake sessions, helping to identify and assess psychological distress and mental illness, thereby supporting clinicians in their diagnostic process.
Early Impact and Support for High-Stress Populations
The LIV platform is already operational across various healthcare settings in Israel, including hospitals, HMOs, rehabilitation centers, and government organizations. Notably, Mentaily is also supporting security forces through collaborations with Israel’s Directorate of Defense Research & Development (DDR&D) and the Ministry of Defense, addressing the unique mental health needs of populations often exposed to high stress and prolonged trauma. The company plans to customize future versions of the platform for additional specific populations, including children, adolescents, and women.
Expansion with New Funding
The $3M seed funding will be instrumental in supporting Mentaily’s ongoing product development and will drive its expansion efforts, both within Israel and into select international markets. The company is also actively recruiting talent to support this growth phase.
